...
首页> 外文期刊>Arthritis & rheumatology. >Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen-Induced Arthritis
【24h】

Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen-Induced Arthritis

机译:选择性的肿瘤坏死因子受体I阻滞剂具有抗炎作用,并揭示了肿瘤坏死因子受体II在胶原诱导的关节炎中的免疫调节作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ObjectiveTumor necrosis factor (TNF) signals via 2 receptors, TNFR type I (TNFRI) and TNFRII, with distinct cellular distribution and signaling functions. In rheumatoid arthritis (RA), the net effect of TNFR signaling favors inflammatory responses while inhibiting the activity of regulatory T cells. TNFRII signaling has been shown to promote Treg cell function. To assess the relative contributions of TNFRI and TNFRII signaling to inflammatory and regulatory responses in vivo, we compared the effect of TNF blockade, hence TNFRI/II, versus TNFRI alone in collagen-induced arthritis (CIA) as a model of RA.
机译:目的肿瘤坏死因子(TNF)通过2种受体TNFR I型(TNFRI)和TNFRII发出信号,具有明显的细胞分布和信号传导功能。在类风湿关节炎(RA)中,TNFR信号传导的净效应有利于炎症反应,同时抑制调节性T细胞的活性。 TNFRII信号已显示促进Treg细胞功能。为了评估TNFRI和TNFRII信号传导对体内炎症和调节反应的相对贡献,我们比较了在胶原诱导的关节炎(CIA)中,作为RA模型的TNF阻滞(即TNFRI / II)与单独的TNFRI的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号